Related Experiment Video

Updated: Jul 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Endovascular and surgical management of carotid artery restenosis]

D Z Sagić1, Z D Antonić, B B Petrović

  • 1Centar za invazivnu dijagnostiku, Institut za kardiovaskularne bolesti Dedinje, Beograd.

Acta Chirurgica Iugoslavica
|November 9, 2007
PubMed

Insights

Endovascular treatment for carotid artery restenosis is safer and more effective than reoperation. This study found fewer serious complications and less restenosis with endovascular methods.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Neurology

Context:

  • Recurrent carotid stenosis after endarterectomy affects 10-34% of patients.
  • A four-year experience comparing reoperation and endovascular treatment for restenosis is presented.

Purpose:

  • To compare the safety and efficacy of reoperation versus endovascular treatment for carotid artery restenosis.
  • To evaluate periprocedural and long-term outcomes in patients undergoing treatment for carotid restenosis.

Summary:

  • Fifty patients (37 men, 13 women) were treated between 2001-2005.
  • No periprocedural strokes, deaths, or myocardial infarctions occurred in either group.
  • The endovascular group had no restenosis >= 50%, while the surgical group had two such cases. Transient ischemic attack rates were 3.17% (endovascular) and 11.76% (surgical). One death from myocardial infarction occurred in the surgical follow-up.

Impact:

  • Endovascular treatment for carotid artery restenosis is a safe and effective alternative to reoperation.
  • Endovascular treatment is associated with a lower incidence of serious complications compared to redo surgery.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...